Skip to main content
NCBI home page
Gut logoLink to Gut
. 1986 Dec;27(12):1408–1413. doi: 10.1136/gut.27.12.1408

Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study.

O Broström, R Löfberg, A Ost, H Reichard
PMCID: PMC1433971  PMID: 3804019

Abstract

An eight year endoscopical and histological cancer surveillance programme comprising 71 patients with ulcerative colitis is presented. Forty one patients had total colitis and 30 substantial colitis. Mean duration of the disease was 19.7 years (range 9-46 years). An average of 2.6 colonoscopies per patient in the total colitis group were carried out, and at least two biopsies were taken at 10 locations in the colon. In the total colitis group, seven had either low (four), or high grade dysplasia (two), or Dukes' A cancer (one). In the group with substantial colitis two patients with low grade dysplasia were found. Dysplasia or cancer leading to operation was found above the rectum in four of five operated patients, all having had total colitis for 25 to 44 years. The dysplasia and cancer findings at the colonoscopy preceding surgery corresponded well with the surgical specimens. In three operated patients a sequence of dysplasia development was recorded. With the exception of long duration and dysplasia, nothing in the clinical course distinguished the operated cases. Using this surveillance programme prophylactic colectomy can be limited to patients in a high risk group developing dysplasia. The risk of missing a cancer before it becomes incurable seems to be low.

Full text

PDF
1408

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackstone M. O., Riddell R. H., Rogers B. H., Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981 Feb;80(2):366–374. [PubMed] [Google Scholar]
  2. DAWSON I. M., PRYSE-DAVIES J. The development of carcinoma of the large intestine in ulcerative colitis. Br J Surg. 1959 Sep;47:113–128. doi: 10.1002/bjs.18004720202. [DOI] [PubMed] [Google Scholar]
  3. De Dombal F. T., Watts J. M., Watkinson G., Goligher J. C. Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. Br Med J. 1966 Jun 11;1(5501):1442–1447. doi: 10.1136/bmj.1.5501.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. EDWARDS F. C., TRUELOVE S. C. THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS. Gut. 1964 Feb;5:1–22. doi: 10.1136/gut.5.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Evans J. G., Acheson E. D. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut. 1965 Aug;6(4):311–324. doi: 10.1136/gut.6.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fuson J. A., Farmer R. G., Hawk A., Sullivan B. H. Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol. 1980 Feb;73(2):120–126. [PubMed] [Google Scholar]
  7. Granqvist S., Gabrielsson N., Sundelin P., Thorgeirsson T. Precancerous lesions in the mucosa in ulcerative colitis. A radiographic, endoscopic, and histopathologic study. Scand J Gastroenterol. 1980;15(3):289–296. doi: 10.3109/00365528009181472. [DOI] [PubMed] [Google Scholar]
  8. Greenstein A. J., Sachar D. B., Smith H., Pucillo A., Papatestas A. E., Kreel I., Geller S. A., Janowitz H. D., Aufses A. H., Jr Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology. 1979 Aug;77(2):290–294. [PubMed] [Google Scholar]
  9. Kewenter J., Ahlman H., Hultén L. Cancer risk in extensive ulcerative colitis. Ann Surg. 1978 Dec;188(6):824–828. doi: 10.1097/00000658-197812000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kewenter J., Hultén L., Ahrén C. The occurrence of severe epithelial dysplasia and its bearing on treatment of longstanding ulcerative colitis. Ann Surg. 1982 Feb;195(2):209–213. doi: 10.1097/00000658-198202000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lennard-Jones J. E., Morson B. C., Ritchie J. K., Shove D. C., Williams C. B. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology. 1977 Dec;73(6):1280–1289. [PubMed] [Google Scholar]
  12. Lennard-Jones J. E., Morson B. C., Ritchie J. K., Williams C. B. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet. 1983 Jul 16;2(8342):149–152. doi: 10.1016/s0140-6736(83)90129-0. [DOI] [PubMed] [Google Scholar]
  13. MACDOUGALL I. P. THE CANCER RISK IN ULCERATIVE COLITIS. Lancet. 1964 Sep 26;2(7361):655–658. doi: 10.1016/s0140-6736(64)92474-2. [DOI] [PubMed] [Google Scholar]
  14. Morson B. C., Pang L. S. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut. 1967 Oct;8(5):423–434. doi: 10.1136/gut.8.5.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Riddell R. H. The precarcinomatous phase of ulcerative colitis. Curr Top Pathol. 1976;63:179–219. doi: 10.1007/978-3-642-66481-6_6. [DOI] [PubMed] [Google Scholar]
  16. Sackett D. L., Whelan G. Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis. Gastroenterology. 1980 Jun;78(6):1632–1635. [PubMed] [Google Scholar]
  17. Watts J. M., De Dombal F. T., Watkinson G., Goligher J. C. Early course of ulcerative colitis. Gut. 1966 Feb;7(1):16–31. doi: 10.1136/gut.7.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Whelan G. Cancer risk in ulcerative colitis: why are results in the literature so varied? Clin Gastroenterol. 1980 May;9(2):469–476. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES